Pharmaceutical companies commonly engage PCT to guide them in commercializing the cell therapy products they are developing or have acquired or licensed.

Pharmaceutical companies see PCT as a valuable resource for development, manufacturing and distribution, and also view PCT as a high-quality economical alternative to implementing equivalent in-house resources. They look to leverage PCT’s long-standing cell therapy expertise to help them assess potential investments, licenses, and acquisitions that they are making in the cell therapy sector.

New Call-to-action